Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

BTIG Downgrades Integra Lifesciences to Neutral

BTIG analyst Ryan Zimmerman downgrades Integra Lifesciences (NASDAQ:IART) from Buy to Neutral.

byvishwanath@benzinga.com

September 15, 2021

1 minute read

BTIG analyst Ryan Zimmerman downgrades Integra Lifesciences (NASDAQ:IART) from Buy to Neutral.

News

Newegg Exclusively Offering First ASRock Gaming Monitors

By Benzinga Newsdesk

Today, 11:53 AM

Curved 34-inch Phantom Gaming monitor features first built-in Wi-Fi antenna for a monitor; available in North America only from Newegg Newegg Commerce, Inc. (NASDAQ:NEGG), a leading global technology e-commerce

NEGG

Analyst Ratings

Where Allscripts Healthcare Stands With Analysts

By Benzinga Insights

Today, 11:53 AM

Allscripts Healthcare (NASDAQ:MDRX) has observed the following analyst ratings within the last quarter:

MDRX

HC Wainwright & Co. Maintains Buy on Elys Game Technology, Lowers Price Target to $2

By Benzinga Newsdesk

Today, 11:53 AM

HC Wainwright & Co. analyst Scott Buck maintains Elys Game Technology (NASDAQ:ELYS) with a Buy and lowers the price target from $3 to $2.

ELYS

A Peek Into The Markets: US Stock Futures Edge Lower; All Eyes On Jobs Report

By Lisa Levin

Today, 11:53 AM

Pre-open movers

AAPL

BTIG Downgrades Integra Lifesciences to Neutral

Related Posts

Newegg Exclusively Offering First ASRock Gaming Monitors

Where Allscripts Healthcare Stands With Analysts

HC Wainwright & Co. Maintains Buy on Elys Game Technology, Lowers Price Target to $2

A Peek Into The Markets: US Stock Futures Edge Lower; All Eyes On Jobs Report